Table 3.
postpartum antihypertensive drugs and the daily mean blood pressures among users
| Day 0 postpartum | Day 1 postpartum | Day 2 postpartum | Day 3 postpartum | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antihypertensive drugs and number of users | BP | Antihypertensive drugs and number of users | BP | Antihypertensive drugs and number of users | BP | Antihypertensive drugs and number of users | BP | ||||||||||
| SBP | DBP | SBP | DBP | SBP | DBP | SBP | DBP | ||||||||||
| None, n = 2 | 110.0 ±0 | 64.0 ±0 | None, n = 9 | 131.61 ±17.53 | 79.88 ±10.74 | None, n = 11 | 140.63 ±7.95 | 87.90 ±6.61 | None, n = 18 | 141.49 ±15.86 | 89.34 ±10.75 | ||||||
| Methyldopa, n = 24 | 133.91 ±13.97 | 81.12 ±11.15 | Methyldopa, n = 12 | 131.52 ±11.05 | 81.49 ±8.35 | Methyldopa, n = 8 | 133.41 ±15.78 | 81.29 ±13.90 | Methyldopa, n = 3 | 138.17 ±2.84 | 87.67 ±9.57 | ||||||
| Methyldopa, hydrallazine, Nifedipine capsule, n = 1 | 175.00 ±0 | 96.00 ±0 | Amlodipine, Hydrallazine, Methyldopa, n = 2 | 137.88 ±4.07 | 88.50 ±7.07 | Hydrallazine, Nifedipine capsule, n = 1 | 147.00 ±0 | 90.00 ±0 | Amlodipine, Enalapril, Hydrallazine, n = 1 | 160.00 ±0 | 110.0 ±0 | ||||||
| Nifedipine XL, n = 1 | 146.00 ±0 | 83.00 ±0 | HCT, Methyldopa, Nifedipine XL, n = 1 | 142.00 ±0 | 72.75 ±0 | HCT, Nifedipine capsule, n = 1 | 156.50 ±0 | 93.00 ±0 | Amlodipine, Enalapril, HCT, n = 2 | 151.25 ±13.44 | 96.13 ±6.89 | ||||||
| Amlodipine, HCT, Methyldopa, n = 2 | 146.30 ±3.54 | 93.00 ±5.66 | Enalapril, n = 1 | 151.75 ±0 | 95.25 ±0 | Amlodipine, Enalapril, HCT, Hydrallazine, n = 1 | 176.00 ±0 | 102.00 ±0 | HCT, n = 4 | 144.33 ±10.96 | 92.08 ±0.58 | ||||||
| Methyldopa, Nifedipine capsule, n = 2 | 137.25 ±1.77 | 79.75 ±8.84 | Amlodipine, n = 5 | 134.50 ±8.77 | 81.85 ±10.01 | Amlodipine, n = 5 | 145.70 ±7.30 | 86.65 ±16.54 | Amlodipine, Hydrallazine, n = 1 | 151.67 ±0 | 94.00 ±0 | ||||||
| Amlodipine, HCT, n = 1 | 130.50 ±0 | 82.00 ±0 | Amlodipine, HCT, Methyldopa, n = 3 | 121.58 ±14.47 | 80.50 ±11.72 | HCT, Methyldopa, n = 1 | 128.75 ±0 | 78.00 ±0 | Amlodipine, Nifedipine capsule, n = 2 | 143.63 ±1.24 | 93.38 ±1.94 | ||||||
| HCT, Methyldopa, Hydrallazine, n = 1 | 122.00 ±0 | 68.50 ±0 | Amlodipine, Enalapril, Methyldopa, n = 1 | 129.75 ±0 | 77.75 ±0 | Amlodipine, Enalapril, HCT, n = 1 | 147.75 ±0 | 88.00 ±0 | Amlodipine, n = 2 | 147.75 ±15.91 | 92.75 ±4.60 | ||||||
| Amlodipine, n = 3 | 135.00 ±21.21 | 75.50 ±2.12 | HCT, Hydrallazine, Methyldopa, n = 1 | 116.00 ±0 | 67.75 ±0 | Amlodipine, Enalapril, Methyldopa, n = 1 | 165.00 ±0 | 103.00 ±0 | Amlodipine, Enalapril, Nifedipine capsule, n = 1 | 154.75 ±0 | 84.50 ±0 | ||||||
| Amlodipine, Methyldopa, n = 5 | 134.85 ±3.68 | 78.35 ±8.12 | Amlodipine, Enalapril, HCT, n = 2 | 124.67 ±21.68 | 80.46 ±12.43 | HCT, Methyldopa, Hydrallazine, n = 1 | 121.50 ±0 | 74.50 ±0 | Enalapril, HCT, n = 1 | 131.00 ±0 | 81.50 ±0 | ||||||
| HCT, n = 1 | 117.00 ±0 | 69.50 ±0 | HCT, Nifedipine capsule, n = 1 | 153.75 ±0 | 90.50 ±0 | Amlodipine, Hydrallazine, n = 1 | 140.00 ±0 | 77.25 ±0 | Enalapril, HCT, Methyldopa, n = 2 | 145.13 ±4.07 | 94.25 ±6.01 | ||||||
| Enalapril, HCT, Methyldopa, n = 1 | 130.00 ±0 | 88.67 ±0 | Amlodipine, Enalapril, n = 2 | 120.0 ±21.21 | 74.00 ±16.26 | Amlodipine, Nifedipine capsule, n = 1 | 152.25 ±0 | 95.25 ±0 | Amlodipine, HCT, Methyldopa, n = 1 | 156.00 ±0 | 101.00 ±0 | ||||||
| Enalapril, HCT, n = 1 | 160.00 ±0 | 89.50 ±0 | HCT, n = 1 | 146.75 ±0 | 95.50 ±0 | Amlodipine, Enalapril, n = 2 | 121.75 ±12.37 | 69.75 ±13.44 | Amlodipine, HCT, Hydrallazine, Methyldopa, n = 1 | 137.25 ±0 | 98.25 ±0 | ||||||
| Methyldopa, hydrallazine, Labetalol iv, n= 1 | 143.00 ±0 | 93.00 ±0 | Methyldopa, Nifedipine capsule, n = 2 | 140.00 ±11.67 | 87.88 ±0.89 | HCT, n = 2 | 131.13 ±14.32 | 85.50 ±11.31 | Amlodipine, Methyldopa, n = 2 | 138.75 ±2.83 | 89.50 ±0 | ||||||
| Enalapril, Furosemide, n = 1 | Missing Data | Missing Data | Amlodipine, Nifedipine capsule, n = 1 | 150.00 ±0 | 94.75 ±0 | Enalapril, HCT, n = 1 | 129.75 ±0 | 86.00 ±0 | Amlodipine, Enalapril, n = 2 | 142.25 ±25.81 | 90.16 ±16.97 | ||||||
| Methyldopa, Hydrallazine, n = 1 | 124.00 ±0 | 78.00 ±0 | Enalapril, HCT, Methyldopa, n = 1 | 133.33 ±0 | 74.00 ±0 | Enalapril, n = 1 | 150.50 ±0 | 93.00 ±00 | Amlodipine, HCT, n = 1 | 139.33 ±0 | 91.00 ±0 | ||||||
| Amlodipine, Methyldopa, n = 3 | 125.78 ±4.13 | 81.03 ±4.14 | Amlodipine, HCT, Methyldopa, n = 1 | 143.33 ±0 | 93.33 ±0 | Enalapril, n = 2 | 138.63 ±16.09 | 76.63 ±9.02 | |||||||||
| HCT, Hydrallazine, Labetalol iv, Methyldopa, n = 1 | 140.00 ±0 | 87.25 ±0 | Enalapril, HCT, Methyldopa, n = 3 | 144.72 ±9.90 | 87.67 ±5.44 | Missing Data, n = 4 | 142.08 ±15.20 | 91.58 ±14.68 | |||||||||
| Enalapril, Furosemide, n = 1 | 130.75 ±0 | 66.75 ±0 | Amlodipine, Methyldopa, n = 3 | 132.94 ±16.88 | 80.33 ±12.19 | ||||||||||||
| Amlodipine, HCT, n = 1 | 143.50 ±0 | 88.25 ±0 | |||||||||||||||
| Enalapril, HCT, Hydrallazine, Labetalol iv, Methyldopa, n = 1 | 151.75 ±0 | 99.00 ±0 | |||||||||||||||
| Enalapril, Furosemide, n = 1 | 139.25 ±0 | 73.75 ±0 | |||||||||||||||
| Methyldopa, Enalapril, n = 1 | 138.75 ±0 | 85.50 ±0 | |||||||||||||||
Abbreviations: BP, Blood pressure; DBP, diastolic blood pressure; hydralazine, monohydrallazine (oral hydrallazine); HCT, hydrochlorothiazide; iv, intravenous; Methyldopa, alpha-methyldopa; Nifedipine capsule, rapid-acting nifedipine; Nifedipine XL, slow-release nifedipine; none, no antihypertensive drug required or administered; SBP, systolic blood pressure.